Welcome to the e-CCO Library!

P367: Significant impact on health care utilization upon implementation of an electronic IBD care management program.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Koppelman, L.(1)*;Roozemoind, S.(1);Cornelissen, L.(2);Hommes, D.(2);Voorneveld, P.(1);Maljaars, J.(1);Kubben, F.(3);Verweij, E.(3);van der Meulen - de Jong, A.(1);
Created: Friday, 14 July 2023, 11:05 AM
P367: The availability of infliximab trough levels in IBD patients on maintenance therapy deeply impacts therapeutic decision-making
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lobaton T.*1, Cañete F.1, Teniente A.2, Cabre E.1,3, Mañosa M.1, Martínez E.2, Domènech E.1,3

Created: Wednesday, 20 February 2019, 10:36 AM
P367: Vedolizumab and early postoperative complications in non-intestinal surgery: A case-matched analysis
Year: 2018
Source: ECCO '18 Vienna
Authors:

P.G. Kotze1*, N. Mckenna2, C. Ma1, A. Almutairdi1, L. Raffals3, E.V. Loftus Jr.3, R. Panaccione1, A. Lightner2

Created: Thursday, 21 February 2019, 9:14 AM
P367: Weight patterns in biologicals treated Inflammatory bowel disease cohort
Year: 2021
Source: ECCO'21 Virtual
Authors: Kaazan, P.(1,2);Tan , Z.(3);Maiyani, P.(1);Mickenbecker, M.(1);Edwards, S.(2);McIvor, C.(1);Andrews , J.M.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P368 Tofacitinib induction efficiency and intracellular cytokine dynamics in ulcerative colitis: Results from clinical practice
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Kolar1, M. Lukas1, K. Malickova1,2, L. Prochazkova1, M. Bortlik1,3,4, D. Duricova1, V. Hruba1, N. Machkova1, K. Mitrova1, M. Vasatko1, M. Lukas1,2

Created: Thursday, 30 January 2020, 10:12 AM
P368: Persistence of biologic therapy and mapping of sequential biologic use: Results of a single centre cohort with 841 patients treated over 18 years
Year: 2018
Source: ECCO '18 Vienna
Authors:

P. Jenkinson*, N. Plevris, C.S. Chuah, M. Lyons, G. Jones, R. Hall, I. Arnott, C. Lees

Created: Thursday, 21 February 2019, 9:14 AM
P368: Proactive Therapeutic Drug Monitoring is more effective than Conventional Management in Inducing Fecal Calprotectin remission in Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Pedro, J.(1);Rodrigues, I.(1);Fernandes, S.(1);Gonçalves, A.R.(1);Bernardo, S.(1);Baldaia, C.(1);Valente, A.(1);Moura Santos, P.(1);Correia, L.(1);Tato Marinho, R.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P368: Risk factors for serious infections in elderly patients receiving infliximab and other Crohn’s disease therapies: TREAT™ registry data
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

G. Lichtenstein1, W. Langholff2, B. Feagan*3, R. Cohen4, B. Salzberg5, J. Popp6, R. Nissinen7, W. J. Sandborn8

Created: Friday, 22 February 2019, 9:49 AM
P368: Safety issues of azathioprine in patients with inflammatory bowel disease: clinical experience from a referral center
Year: 2022
Source: ECCO'22
Authors: Fousekis, F.(1);Kourtis, G.(1);Saridi, M.(1);Albani, E.(1);Katsanos, K.(1);Christodoulou, D.(1);
Created: Friday, 11 February 2022, 3:52 PM
P368: The presence of extra-intestinal manifestations is associated with poor prognosis in acute severe ulcerative colitis: A KASID multicenter study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kim, D.H.(1);Kim, E.S.(2);Kim, H.S.(3)*;Park, S.H.(4);Kim, S.J.(5);Kim, K.O.(6);Lee, Y.J.(7);Song, E.M.(8);Kim, D.S.(9);Lee, J.(5);
Created: Friday, 14 July 2023, 11:05 AM
P368: Treatment of inflammatory bowel disease in the elderly
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Roque Ramos L.*1, Barosa R.1, Mocanu I.2, Patita M.1, Nunes G.1, Vieira A.I.1

Created: Wednesday, 20 February 2019, 10:36 AM
P368: Vedolizumab in inflammatory bowel disease: a retrospective single-centre study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Larsson*1, M. Henriksen1, L-P. Jelsness-Jørgensen1,2, A. Rekvin3, F. Lerang1

Created: Friday, 22 February 2019, 9:41 AM
P369 Mycobacterium tuberculosis infection among patients with inflammatory bowel disease under biologics: experience of Croatian Tertiary Centre
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. Ogresta, A. Bišćanin, V. Tomašić, Z. Dorosulić, D. Kralj, J. Forgač, P. Ćaćić, I. Lerotić, D. Hrabar

Created: Thursday, 30 January 2020, 10:12 AM
P369: Do teenager and adult onset Crohn´s disease patients have different outcomes? A Portuguese cohort study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Cerqueira, R.(1)*;Correia, M.(1);Veloso, R.(1);Manso, M.C.(2);
Created: Friday, 14 July 2023, 11:05 AM
P369: Dual Biologic in Moderate to Severe Pediatric Inflammatory Bowel Disease: A Case Series
Year: 2022
Source: ECCO'22
Authors: Wlazło, M.(1);Jarzębicka, D.(1);Meglicka, M.(1);Kierkuś, J.(1);
Created: Friday, 11 February 2022, 3:52 PM
P369: Efficacy of infliximab after failure of subcutaneous anti-TNF agents in patients with ulcerative colitis: A multicentre study
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Streichenberger1*, B. Pariente2, A. Bozon3, N. Arab4, A. Amiot5, L. Vuitton6, M. Tilmant7, M. Nachury8, R. Altwegg3, T. Delasalle4, C. Gagnière5, B. Grégoire6, M. Fumery7, P. Wils2, G. Pineton de Chambrun3, X. Hébuterne4, B. Pereira9, G. Bommelaer1,10, A. Buisson1,10

Created: Thursday, 21 February 2019, 9:14 AM
P369: High prevalence of abdominal pain in Crohn's Disease patients of the TRUST study cohort- Is there a connection to inflammatory activity?
Year: 2021
Source: ECCO'21 Virtual
Authors: Kugel, T.(1);Maaser, C.(2);Kucharzik, T.(3);Fischer, I.(4);Kolterer, S.(5);Hammer, L.(5);Rath, S.(5);Sturm, A.(6);
Created: Wednesday, 2 June 2021, 4:12 PM
P369: Improvement in patient-reported outcomes in 2 Phase 3 studies of tofacitinib in patients with moderately to severely active ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

J. Panés*1, C. Su2, A. Marren2, D. Yu2, D. Woodworth2, H. Zhang2, P. Healey3

Created: Friday, 22 February 2019, 9:49 AM
P369: Safety and lymphocyte-lowering properties of etrasimod (APD334), an oral, potent, next-generation, selective S1P receptor modulator, after dose escalation in healthy volunteers
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Peyrin-Biroulet L.1, Christopher R.2, Trokan L.2, Lassen C.2, Adams J.2, Kühbacher T.*3

Created: Wednesday, 20 February 2019, 10:36 AM
P369: The comparative frequency of clostridial infection in patients with ulcerative colitis receiving mesenchymal stromal cells and anti-cytokine therapy
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

O. Knyazev1, A. Kagramanova*1, M. Chernova2, I. Korneeva1, D. Kulakov1, A. Parfenov1

Created: Friday, 22 February 2019, 9:41 AM